翻訳と辞書 |
Ensemble Therapeutics : ウィキペディア英語版 | Ensemble Therapeutics
Ensemble Therapeutics Corporation is a privately held pharmaceutical and biotechnology company in Cambridge, Massachusetts. Founded in 2004 by Harvard chemist David R. Liu, the company develops and is attempting to bring to market synthetic macrocycle drugs, that is, compounds with a characteristic macrocyclic ring structure, under the trademark Ensemblins. If successful, Ensemblins would be a new class of drugs between small molecules and biologics. An orally active antagonist to Interleukin 17 has been demonstrated in animal models.〔("Ensemble Therapeutics Fact Sheet" ) (November 28, 2012)〕 ==Management== John Ripple became chief executive officer in 2013. Nick K. Terrett has been the chief scientific officer since 2006. Founder David R. Liu chairs the scientific advisory board.〔BloombergBusinessweek, ("Company Overview of Ensemble Therapeutics Corporation" )〕
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Ensemble Therapeutics」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|